ArticleFrontiers in endocrinology2026
Association between triglyceride-glucose-related indices and liver-related events in patients with type 2 diabetes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accumulating evidence has linked the triglyceride-glucose (TyG) index and its derived measures to a broad range of diabetic complications. However, the nature of the association between these indices and subsequent liver morbidity in type 2 diabetes (T2D) patients warrants further investigation. The present analysis assessed the prospective associations between four TyG-based parameters and the incidence of liver-related events (LRE) among people with T2D. Methods: This prospective cohort study included 18,105 participants with T2D from the UK Biobank. Four TyG-related indices were assessed, including TyG, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), and TyG-waist-to-height ratio (TyG-WHtR). Cox proportional hazards models and restricted cubic spline (RCS) were used to evaluate the associations between TyG-related indices and incident LRE risk. Results: During a median follow-up of 13.4 years, 507 T2D patients developed LRE. Compared to patients in the lowest quartile, those in the highest quartiles of both TyG-WC (HR = 1.63, 95% CI 1.12-2.38) and TyG-WHtR (HR = 1.98, 95% CI 1.36-2.89) were associated with increased risk of LRE. Restricted cubic spline models confirmed linear relationships for both TyG-WC and TyG-WHtR with LRE risk. No significant associations of TyG and TyG-BMI with LRE risk were observed. Subgroup analyses demonstrated that the associations between TyG-WC/TyG-WHtR and LRE were more pronounced in high-risk populations, including excessive alcohol consumers and individuals with FIB-4 scores ≥1.3 (indicating higher liver fibrosis risk). For instance, the association between TyG-WHtR and LRE was stronger in individuals with FIB-4 ≥1.3 (HR = 2.59, 95% CI 1.65-4.07) compared to those with FIB-4 <1.3 (HR = 1.58, 95% CI 0.76-3.29). Conclusion: Among T2D patients, TyG-WC and TyG-WHtR were consistently associated with increased risk of LRE, confirming the independent clinical utility of these indices. These findings demonstrate that both indices may serve as efficient, cost-effective, and practical tools for enhancing the identification and stratification of LRE risk in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.